PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

作者: Nazneen Rahman , Sheila Seal , Deborah Thompson , Patrick Kelly , Anthony Renwick

DOI: 10.1038/NG1959

关键词:

摘要: PALB2 interacts with BRCA2, and biallelic mutations in (also known as FANCN), similar to BRCA2 mutations, cause Fanconi anemia. We identified monoallelic truncating 10/923 individuals familial breast cancer compared 0/1,084 controls (P = 0.0004) show that such confer a 2.3-fold higher risk of (95% confidence interval (c.i.) 1.4–3.9, P 0.0025). The results is susceptibility gene further demonstrate the close relationship anemia–DNA repair pathway predisposition.

参考文章(15)
Anthony Renwick, Deborah Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard North, Hiran Jayatilake, Rita Barfoot, Katarina Spanova, Lesley McGuffog, D Gareth Evans, Diana Eccles, Douglas F Easton, Michael R Stratton, Breast Cancer Susceptibility Collaboration (UK), Nazneen Rahman, None, ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nature Genetics. ,vol. 38, pp. 873- 875 ,(2006) , 10.1038/NG1837
Bing Xia, Qing Sheng, Koji Nakanishi, Akihiro Ohashi, Jianmin Wu, Nicole Christ, Xinggang Liu, Maria Jasin, Fergus J. Couch, David M. Livingston, Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2 Molecular Cell. ,vol. 22, pp. 719- 729 ,(2006) , 10.1016/J.MOLCEL.2006.05.022
Orna Levran, Claire Attwooll, Rashida T Henry, Kelly L Milton, Kornelia Neveling, Paula Rio, Sat Dev Batish, Reinhard Kalb, Eunike Velleuer, Sandra Barral, Jurg Ott, John Petrini, Detlev Schindler, Helmut Hanenberg, Arleen D Auerbach, The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia Nature Genetics. ,vol. 37, pp. 931- 933 ,(2005) , 10.1038/NG1624
Yosef Shiloh, The ATM-mediated DNA-damage response: taking shape Trends in Biochemical Sciences. ,vol. 31, pp. 402- 410 ,(2006) , 10.1016/J.TIBS.2006.05.004
A C Antoniou, D F Easton, Models of genetic susceptibility to breast cancer. Oncogene. ,vol. 25, pp. 5898- 5905 ,(2006) , 10.1038/SJ.ONC.1209879
Toshiyasu Taniguchi, Alan D. D'Andrea, Molecular pathogenesis of Fanconi anemia: recent progress. Blood. ,vol. 107, pp. 4223- 4233 ,(2006) , 10.1182/BLOOD-2005-10-4240
Bing Xia, Josephine C Dorsman, Najim Ameziane, Yne de Vries, Martin A Rooimans, Qing Sheng, Gerard Pals, Abdellatif Errami, Eliane Gluckman, Julian Llera, Weidong Wang, David M Livingston, Hans Joenje, Johan P de Winter, Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nature Genetics. ,vol. 39, pp. 159- 161 ,(2007) , 10.1038/NG1942
Niall G Howlett, Toshiyasu Taniguchi, Susan Olson, Barbara Cox, Quinten Waisfisz, Christine de Die-Smulders, Nicole Persky, Markus Grompe, Hans Joenje, Gerard Pals, Hideyuki Ikeda, Edward A Fox, Alan D D'Andrea, Biallelic Inactivation of BRCA2 in Fanconi Anemia Science. ,vol. 297, pp. 606- 609 ,(2002) , 10.1126/SCIENCE.1073834
Marieke Levitus, Quinten Waisfisz, Barbara C Godthelp, Yne de Vries, Shobbir Hussain, Wouter W Wiegant, Elhaam Elghalbzouri-Maghrani, Jûrgen Steltenpool, Martin A Rooimans, Gerard Pals, Fré Arwert, Christopher G Mathew, Małgorzata Z Zdzienicka, Kevin Hiom, Johan P De Winter, Hans Joenje, The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J Nature Genetics. ,vol. 37, pp. 934- 935 ,(2005) , 10.1038/NG1625